Published in Lab Business Week, September 4th, 2005
Consolidated revenues for the second quarter 2005 were $74.8 million compared to $65.8 million for the same period in 2004, an increase of 13.7%. Consolidated R&D expenses net of tax credits amounted to $7.6 million in the second quarter of 2005 compared to $8.7 million in the second quarter of 2004, a decrease of 12.6%.
Consolidated earnings from operations for the second quarter 2005 were $4.3 million, compared to $9.2 million for the second quarter 2004, a decrease of 53.2%.
On the other hand, the company's...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.